<SEC-DOCUMENT>0000947871-15-000713-index.html : 20151002
<SEC-HEADER>0000947871-15-000713.hdr.sgml : 20151002
<ACCEPTANCE-DATETIME>20151002172528
ACCESSION NUMBER:		0000947871-15-000713
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20151002
DATE AS OF CHANGE:		20151002
GROUP MEMBERS:		ORBIMED CAPITAL GP V LLC
GROUP MEMBERS:		SAMUEL D. ISALY

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89113
		FILM NUMBER:		151141438

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORBIMED ADVISORS LLC
		CENTRAL INDEX KEY:			0001055951
		IRS NUMBER:				133976876
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(212) 739-6400

	MAIL ADDRESS:	
		STREET 1:		601 LEXINGTON AVENUE
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>ss454757_sc13d.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
Document 1 - file: ss454757_sc13d.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ss454757_ex9901.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ss454757_ex9901.htm

</DOCUMENT>
</SEC-DOCUMENT>